Stay updated on SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial

Sign up to get notified when there's something new on the SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The update includes a minor site-version revision (Revision: v3.4.2) and removal of a government-operating-status notice; no study content, eligibility criteria, or results are affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T16:29:28.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    A government funding lapse notice was added and the revision tag updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:48:12.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    UI and metadata updates were applied: a 'Show glossary' toggle is now shown, and QC-related labels were updated to 'Last Update Submitted that Met QC Criteria' with a new 'Revision: v3.4.0'. The 'No FEAR Act Data' label is present and older variant labels were removed.
    Difference
    0.2%
    Check dated 2026-01-28T06:53:05.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The page shows a new revision label 'Revision: v3.3.4', replacing the previous 'v3.3.3', with no observed changes to core content, eligibility criteria, or contacts. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:40:00.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    Footer notes now show Revision: v3.3.3; the HHS Vulnerability Disclosure and Revision: v3.3.2 entries were removed.
    Difference
    0.1%
    Check dated 2025-12-23T22:37:33.000Z thumbnail image
  9. Check
    101 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and v3.2.0 was removed. This update does not modify the study details, eligibility criteria, endpoints, or other substantive content on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T13:47:45.000Z thumbnail image

Stay in the know with updates to SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial page.